Skip to main content
Log in

Use of antiparkinsonian drugs in the Umbria Region

  • ORIGINAL
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

Discussion of differences between recommended guidelines and clinical practice is very useful in medicine. The use of a computerized database of all prescriptions of antiparkinsonian drugs enabled us to perform an epidemiological population-based study with low cost and in a relatively short time. We have identified 2 827 parkinsonian patients in November 2000 and estimate the number of patients taking dopaminoagonists aged >75 years, antidepressive drugs, and atypical neuroleptics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanacore, N., Bianchi, C., Da Cas, R. et al. Use of antiparkinsonian drugs in the Umbria Region. Neurol Sci 24, 221–222 (2003). https://doi.org/10.1007/s10072-003-0140-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-003-0140-0

Keywords

Navigation